249 related articles for article (PubMed ID: 12881702)
1. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells.
Kurosu T; Fukuda T; Miki T; Miura O
Oncogene; 2003 Jul; 22(29):4459-68. PubMed ID: 12881702
[TBL] [Abstract][Full Text] [Related]
2. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
3. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
Jardin F; Sahota SS
Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
[TBL] [Abstract][Full Text] [Related]
4. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
Jardin F; Ruminy P; Bastard C; Tilly H
Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
[TBL] [Abstract][Full Text] [Related]
5. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
6. Prevention of etoposide-induced apoptosis by proteasome inhibitors in a human leukemic cell line but not in fresh acute leukemia blasts. A differential role of NF-kappab activation.
Watanabe K; Kubota M; Hamahata K; Lin Y; Usami I
Biochem Pharmacol; 2000 Sep; 60(6):823-30. PubMed ID: 10930537
[TBL] [Abstract][Full Text] [Related]
7. The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene.
Lossos IS; Akasaka T; Martinez-Climent JA; Siebert R; Levy R
Leukemia; 2003 Jul; 17(7):1390-7. PubMed ID: 12835729
[TBL] [Abstract][Full Text] [Related]
8. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
9. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation.
Chen W; Iida S; Louie DC; Dalla-Favera R; Chaganti RS
Blood; 1998 Jan; 91(2):603-7. PubMed ID: 9427715
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb.
Lauricella M; D'Anneo A; Giuliano M; Calvaruso G; Emanuele S; Vento R; Tesoriere G
Cell Death Differ; 2003 Aug; 10(8):930-2. PubMed ID: 12868001
[No Abstract] [Full Text] [Related]
11. Internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma.
Nakamura Y
Leuk Lymphoma; 2000 Aug; 38(5-6):505-12. PubMed ID: 10953971
[TBL] [Abstract][Full Text] [Related]
12. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
13. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis.
Chen C; Lin H; Karanes C; Pettit GR; Chen BD
Cancer Res; 2000 Aug; 60(16):4377-85. PubMed ID: 10969781
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
Zhang XM; Lin H; Chen C; Chen BD
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
[TBL] [Abstract][Full Text] [Related]
15. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production.
Wu HM; Chi KH; Lin WW
FEBS Lett; 2002 Aug; 526(1-3):101-5. PubMed ID: 12208513
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol induces apoptosis in transformed follicular lymphoma OCI-LY8 cells: evidence for a novel mechanism involving inhibition of BCL6 signaling.
Faber AC; Chiles TC
Int J Oncol; 2006 Dec; 29(6):1561-6. PubMed ID: 17088997
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibitors stimulate interleukin-8 expression via Ras and apoptosis signal-regulating kinase-dependent extracellular signal-related kinase and c-Jun N-terminal kinase activation.
Wu HM; Wen HC; Lin WW
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):234-43. PubMed ID: 12151316
[TBL] [Abstract][Full Text] [Related]
19. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystin-induced apoptosis of retinal pigment epithelial cells.
Kim JM; Bae HR; Park BS; Lee JM; Ahn HB; Rho JH; Yoo KW; Park WC; Rho SH; Yoon HS; Yoo YH
J Pharmacol Exp Ther; 2003 May; 305(2):474-81. PubMed ID: 12606642
[TBL] [Abstract][Full Text] [Related]
20. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.
Ettenberg SA; Rubinstein YR; Banerjee P; Nau MM; Keane MM; Lipkowitz S
Mol Cell Biol Res Commun; 1999 Aug; 2(2):111-8. PubMed ID: 10542134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
